Proceedings of the Tenth International Conference of Drug Regulatory Authorities (ICDRA) - Hong Kong, China, 24 - 27 June 2002
(2002; 166 pages) View the PDF document
Table of Contents
View the documentAbbreviations and acronyms used in this report
Open this folder and view contentsOpening ceremony
Open this folder and view contentsHerbal medicines
Open this folder and view contentsKeynote address
Open this folder and view contentsSafety of blood-derived products
Close this folderAntimicrobial resistance - new initiatives
View the documentWHO’s global strategy for the containment of antimicrobial resistance
View the documentImplementing a strategy for the containment of antimicrobial resistance: experience in Uganda
View the documentVeterinary issues contributing to antimicrobial resistance
View the documentStatus of regulation of antimicrobials in Cuba
View the documentFighting antibiotic resistance in Sweden
View the documentAntimicrobial use in Chile - the impact of regulatory measures
View the documentRecommendations
Open this folder and view contentsHarmonization I
Open this folder and view contentsHarmonization II
Open this folder and view contentsProtection of trial subjects in clinical trials
Open this folder and view contentsRegulating biotechnology products
Open this folder and view contentsRegulatory challenges: health sector reform and drug regulatory capacity
Open this folder and view contentsAccess to drugs and vaccines I
Open this folder and view contentsAccess to drugs and vaccines II
Open this folder and view contentsCounterfeit pharmaceutical products
Open this folder and view contentsHomoeopathy
Open this folder and view contentsSafety monitoring
Open this folder and view contentsE-Commerce
Open this folder and view contentsCurrent topics
Open this folder and view contentsRegulatory challenges of new technologies
View the documentList of participants
View the documentBack cover
 

Recommendations

Antmicrobial resistance is a threat to effective treatment of infectious diseases. Since the topic was first discussed at the ICDRA in 1996, much has been accomplished in this area. However, if the emergence of resistance is to be slowed, much more needs to be done. The following are urgent recommendations for all regulatory authorities to implement.

1. All countries should make containment of antimicrobial resistance a national priority by creating an intersectoral task-force to bring together all interested parties and ensure collaboration among the various professional groups.

2. National systems should be created to monitor and analyse antimicrobial usage in food animals and humans by collecting data from hospitals and in the community and linking these findings to resistance and disease surveillance data.

3. Efforts should continue in regulating anti-microbials, while addressing the need for availability at all levels of the health care system.

4. Promotional activities should continue to be regulated by ensuring adherence to guidelines for ethical promotion of medicines.

5. Education of health professionals in rational prescribing and of patients in compliance should be encouraged. Awareness of antimicrobial resistance should be raised within regulatory authorities.

6. The pharmaceutical industry should pay particular attention to GMP and quality issues in relation to the production of antimicrobials, as well as to labelling of their products.

7. Regional and international collaboration should continue and progress reported back to the ICDRA.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014